Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Karayiannakos, P"'
Moxifloxacin (MXF) is an 8-methoxyquinolone with high activity against Gram-positive bacteria. In an experimental model of aortic valve endocarditis (EAVE), the efficacy of MXF was evaluated against a strain of methicillin-resistant Staphylococcus au
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::784e43acdb5afd673bcc24e127c127c2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3131615
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3131615
The beneficial effects of therapy combining an antibiotic and dexamethasone have been reported in human studies on meningitis and in experimental studies on septic arthritis, nephritis, and endophthalmitis. Since most patients with staphylococcal end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::347fc4753d44e6a0ccab7480674596eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3023004
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3023004
Azithromycin and ampicillin protected 94 and 72% of animals challenged with Streptococcus oralis, respectively (P = 0.177), while azithromycin and vancomycin protected 59 and 94% of the methicillin -resistant Staphylococcus aureus (MRSAchallenged ani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::679ac1c985b34d08fab060288828e663
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3053407
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3053407
Single-dose trovafloxacin (15 mg/kg given intravenously [i.v.]) and ampicillin (40 mg/kg given i.v.) protected 38 and 33% of animals challenged with an ampicillin-tolerant strain of Streptococcus oralis, respectively. As a double-dose regimen, trovaf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::19345818b78d1903b9e0c7ba76d0a15d
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3053779
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3053779
Teicoplanin is a glycopeptide antibiotic that is administered both intramuscularly and intravenously. It has a prolonged half-life and a less toxic profile in comparison to those of vancomycin. The efficacy of a single dose of teicoplanin (18 mg/kg o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::cd3c5816063eb3b07d14c1fc4889ba6c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3049523
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3049523
The in vivo efficacies of ciprofloxacin, imipenem and their combination were studied in the rabbit left-sided endocarditis model by using a seroresistant strain of Pseudomonas aeruginosa with borderline susceptibilities to ciprofloxacin (MIC/MBC 1/2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::63e2b8b27e71821bdbc46e98f1c93ac0
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3048163
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3048163
Using a rabbit model of aortic valve endocarditis, we studied the efficacy of vancomycin alone or in combination with netilmicin and/or rifampin against a methicillin- and gentamicin-resistant strain of Staphylococcus aureus (MGRSA). Antibiotics were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::d508a174d9d55842ddaa7f1d82dc74d8
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3047560
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3047560
The in vivo efficacies of ceftazidime, aztreonam, and the combinations of ceftazidime with amikacin and aztreonam with amikacin were studied in the rabbit left-sided endocarditis model by using two strains of Pseudomonas aeruginosa, one multisuscepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::94dfd792ecafe64d261d40c0726a2007
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3045526
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3045526
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.